Skip to search boxSkip to navigationSkip to main content

Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice

  • M. Neale Weitzmann(corresponding author)
    ,
  • Susanne Roser-Page
    ,
  • Tatyana Vikulina
    ,
  • Daiana Weiss
    ,
  • Li Hao
    ,
  • W. Hunter Baldwin
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Hemophilia A (HA), a rare X-linked recessive genetic disorder caused by insufficient blood clotting factor VIII, leaves affected individuals susceptible to spontaneous and traumatic hemorrhage. Although males generally exhibit severe symptoms, due to variable X inactivation, females can also be severely impacted. Osteoporosis is a disease of the skeleton predisposing patients to fragility fracture, a cause of significant morbidity and mortality and a common comorbidity in HA. Because the causes of osteoporosis in HA are unclear and in humans confounded by other traditional risk factors for bone loss, in this study, we phenotyped the skeletons of F8 total knockout (F8TKO) mice, an animal model of severe HA. We found that trabecular bone accretion in the axial and appendicular skeletons of male F8TKO mice lagged significantly between 2 and 6 months of age, with more modest cortical bone decline. By contrast, in female mice, diminished bone accretion was mostly limited to the cortical compartment. Interestingly, bone loss was associated with a decline in bone formation in male mice but increased bone resorption in female mice, a possible result of sex steroid insufficiency. In conclusion, our studies reveal a sexual dimorphism in the mechanism driving bone loss in male and female F8TKO mice, preventing attainment of peak bone mass and strength. If validated in humans, therapies aimed at promoting bone formation in males but suppressing bone resorption in females may be indicated to facilitate attainment of peak mass in children with HA to reduce the risk for fracture later in life.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 288-300 (13 pages)

Journal (Volume, Issue Number)

Blood Advances (Volume 3, Issue 3)

Publication milestones

  • Published - 02/12/2019

Publication status

Published - 02/12/2019

ISSN

2473-9529

Publication IDs

  • Scopus: 85060961072
  • PubMed: 30700417

Publication metrics

Metrics

Fractional count
1
Fractional count
0.09
Fractional count
10
Fractional count
0.91
Fractional count
1
Fractional count
1
SciVal
FWCI
0.72
SciVal
Author count
11
SciVal
citations
5
SciVal
Paper percentile
76
Scopus
citations

PlumX, opens in new tab

Captures
23
Citation count
22

Funding Details

FunderFunding number
NIA
P01AG036675